Repligen | RGEN - Interest Income


Repligen reported $7.31M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Align Technology USD 3.25M 390K Sep/2025
Bio Techne USD 971K 386K Sep/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Bruker USD 2.9M 200K Jun/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Danaher USD 1.27 8M Sep/2025
Dentsply International USD 4M 1000K Mar/2025
Exact Sciences USD -5.29 5.08 Dec/2024
General Electric Aerospace USD 162M 2M Sep/2025
Henry Schein USD 0.84 9M Sep/2025
Illumina USD 0.98 10M Sep/2025
IQVIA Holdings USD 10M 1000K Jun/2025
Myriad Genetics USD 300K 0 Mar/2025
Pfizer USD 0.62 156M Sep/2025
Repligen USD 7.31M 979K Mar/2025
Revvity USD 0.4 8.34M Sep/2025
Standard Biotools USD 2.14M 321K Sep/2025
Thermo Fisher Scientific USD 4.27 297M Sep/2025
Waters USD 2.5 4.51M Sep/2025
West Pharmaceutical Services USD 3.6M 500K Jun/2025